EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom +29.1% ·
netto nieuwe posities +5.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 165 | -6 | 426.85M | $38.52B | +2 | −7 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | — | — |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | — | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | — |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | — | 60.09M | $5.55B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 31.53M | +86.3% | $2.08B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 13.52M | +2.1% | $889.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 13.52M | +2.1% | $889.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 9.08M | +9.8% | $599.08M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (passief) | 7.22M | -15.4% | $476.46M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 3.73M | +4900.6% | $246.39M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 3.73M | +4900.6% | $246.39M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 3.54M | -51.7% | $233.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 3.54M | -51.7% | $233.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 1.99M | +218.9% | $131.42M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 1.99M | +218.9% | $131.42M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | PRIMECAP Management ✦ | 1.78M | -1.4% | $117.77M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 1.22M | Nieuw | $80.62M | 0.1% | New | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 1.14M | +117.7% | $75.30M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 983.22K | +996.7% | $64.88M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 983.22K | +996.7% | $64.88M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 834.75K | +28.5% | $55.09M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 26 | Soros Fund Management ✦ | 300.00K | Nieuw | $19.80M | 0.6% | New | 1 | SEC ↗ |
| 27 | Baillie Gifford ✦ | 208.70K | -40.8% | $13.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Baillie Gifford ✦ | 208.70K | -40.8% | $13.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Baillie Gifford ✦ | 208.70K | -40.8% | $13.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 208.70K | -40.8% | $13.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Bridgewater Associates ✦ | 165.45K | -68.2% | $10.92M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 145.58K | -52.9% | $9.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 145.58K | -52.9% | $9.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 145.58K | -52.9% | $9.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Arrowstreet Capital ✦ | 89.78K | -60.1% | $5.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 74.57K | -51.0% | $4.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Gotham Asset Management ✦ | 7.98K | -32.7% | $526,534 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $80.62M | 0.1% |
| Soros Fund Management | $19.80M | 0.6% |
Verlaten
| Point72 Asset Management | $41.03M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 4 houders, 229.24K aandelen, $319,498 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 619 aand · $56,967
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie